Asuransi Multi Artha Guna Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Asuransi Multi Artha Guna Tbk trades at Rp390 (market cap 1.95T, 15.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume). The key difference: Asuransi Multi Artha Guna Tbk is far larger — about 11.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (43.9K versus 15.9K). Which is the better fit depends on your goals.
| AMAG | OBAT | |
|---|---|---|
Market Cap | 1.95T | 164.65B |
Volume | 15.9K | 43.9K |
Lot | 159 | 439 |
Turnover | 6.2M | 10.6M |
Average Price | 389.99 | 241.43 |
Value | 6.2M | 10.6M |
Indicative Equilibrium Price | 390 | 238 |
Indicative Equilibrium Volume | 100 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Asuransi Multi Artha Guna Tbk (the company) was established at Nov 14, 1980 in Surabaya and at Sept 5, 1997 was moved to Jakarta. The Company's articles of association has been amended from time to time, the latest amendment regarding the change in the Company's status from private company to public company.
Read more on AMAG →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →